相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect of artesunate on immune cells in ret-transgenic mouse melanoma model
Marcel Ramacher et al.
ANTI-CANCER DRUGS (2009)
The Role of Downstream Signaling Pathways of the Epidermal Growth Factor Receptor for Artesunate's Activity in Cancer Cells
V. Badireenath Konkimalla et al.
CURRENT CANCER DRUG TARGETS (2009)
New Developments in Anthracycline-Induced Cardiotoxicity
A. Mordente et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Evaluation of the developmental toxicity of artemether during different phases of rat pregnancy
M. H. El-Dakdoky
FOOD AND CHEMICAL TOXICOLOGY (2009)
Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial
M. F. Gomes et al.
LANCET (2009)
Embryotoxicity of the artemisinin antimalarials and potential consequences for use in women in the first trimester
Robert L. Clark
REPRODUCTIVE TOXICOLOGY (2009)
Artesunate: Developmental toxicity and toxicokinetics in monkeys
Robert L. Clark et al.
BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY (2008)
Developmental toxicity of artesunate in the rat: Comparison to other artemisinins, comparison of embryotoxicity and kinetics by oral and intravenous routes, and relationship to maternal reticulocyte count
Robert L. Clark et al.
BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY (2008)
Embryotoxicity of artesunate in animal species related to drug tissue distribution and toxicokinetic profiles
Qigui Li et al.
BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY (2008)
Sensitive periods for developmental toxicity of orally administered artesunate in the rat
Tacey E. K. White et al.
BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY (2008)
Artesunate derived from traditional Chinese medicine induces DNA damage and repair
Paul C. H. Li et al.
CANCER RESEARCH (2008)
Monitoring and evaluation of malaria in pregnancy - developing a rational basis for control
Bernard J. Brabin et al.
MALARIA JOURNAL (2008)
Monitoring antimalarial safety and tolerability in clinical trials: A case study from Uganda
Sarah G. Staedke et al.
MALARIA JOURNAL (2008)
Effect of artemisinins and other endoperoxides on nitric oxide-related signaling pathway in RAW 264.7 mouse macrophage cells
V. Badireenath Konkimalla et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2008)
Open-Label Comparative Clinical Study of Chlorproguanil-Dapsone Fixed Dose Combination (Lapdap™) Alone or with Three Different Doses of Artesunate for Uncomplicated Plasmodium falciparum Malaria
Daniel G. Wootton et al.
PLOS ONE (2008)
Toxicity of artemisinin [Artemisia annua L.] in two different periods of pregnancy in Wistar rats
Ana C. Boareto et al.
REPRODUCTIVE TOXICOLOGY (2008)
Investigations of the effects of the antimalarial drug dihydroartemisinin (DHA) using the Frog Embryo Teratogenesis Assay-Xenopus (FETAX)
Monica Longo et al.
REPRODUCTIVE TOXICOLOGY (2008)
Induction of apoptosis by artemisinin relieving the severity of inflammation in caerulein-induced acute pancreatitis
Ming Zhao et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Anti-inflammatory properties and regulatory mechanism of a novel derivative of artemisinin in experimental autoimmune encephalomyelitis
Zhaojun Wang et al.
JOURNAL OF IMMUNOLOGY (2007)
Artesunate attenuates the growth of human colorectal carcinoma and inhibits hyperactive Wnt/β-catenin pathway
Lin-Na Li et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Role of Transferrin Receptor and the ABC Transporters ABCB6 and ABCB7 for Resistance and Differentiation of Tumor Cells towards Artesunate
Gerhard Kelter et al.
PLOS ONE (2007)
Artesunate Induces ROS-Mediated Apoptosis in Doxorubicin-Resistant T Leukemia Cells
Thomas Efferth et al.
PLOS ONE (2007)
The safety of artemisinins during pregnancy: a pressing question
Stephanie Dellicour et al.
MALARIA JOURNAL (2007)
Toxicity evaluation of artesunate and artelinate in Plasmodium berghei-infected and uninfected rats
Qigui Li et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2007)
Willmar Schwabe Award 2006: Antiplasmodial and antitumor activity of arternisinin - From bench to bedside
Thomas Efferth
PLANTA MEDICA (2007)
Anti-malarial agent artesunate inhibits TNF-alpha-induced production of proinflammatory cytokines via inhibition of NF-kappa B and PI3 kinase/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes
H. Xu et al.
RHEUMATOLOGY (2007)
Vaccines against malaria - an update
Kai Matuschewski et al.
FEBS JOURNAL (2007)
Neurotoxicity and toxicokinetics of artelinic acid following repeated oral administration in rats
Yuanzheng Si et al.
INTERNATIONAL JOURNAL OF TOXICOLOGY (2007)
The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria
Rose McGready et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Population pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patients
Julie A. Simpson et al.
PLOS MEDICINE (2006)
In vivo and in vitro investigations of the effects of the antimalarial drug dihydroartemisinin (DHA) on rat embryos
Monica Longo et al.
REPRODUCTIVE TOXICOLOGY (2006)
Artesunate-induced depletion of embryonic erythroblasts precedes embryolethality and teratogenicity in vivo
Tacey E. K. White et al.
BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY (2006)
Dihydroarteannuin ameliorates lupus symptom of BXSB mice by inhibiting production of TNF-alpha and blocking the signaling pathway NF-kappa B translocation
Wei-Dong Li et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2006)
Re-evaluation of how artemisinins work in light of emerging evidence of in vitro resistance
Sanjeev Krishna et al.
TRENDS IN MOLECULAR MEDICINE (2006)
Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether-lumefantrine in an area of Uganda where malaria is highly endemic
C Dokomajilar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells
T Efferth
CURRENT DRUG TARGETS (2006)
Malaria parasites can develop stable resistance to artemisinin but lack mutations in candidate genes atp6 (Encoding the sarcoplasmic and endoplasmic reticulum Ca2+ ATPase), tctp, mdr1, and cg10
A Afonso et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Antimalarial Drugs in Pregnancy: A Review
Francois Nosten et al.
CURRENT DRUG SAFETY (2006)
Some pregnancy-related effects of artemether in laboratory animals
Janet I. Ejiofor et al.
PHARMACOLOGY (2006)
Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6
R Jambou et al.
LANCET (2005)
Toxic brainstem encephalopathy after artemisinin treatment for breast cancer
LA Panossian et al.
ANNALS OF NEUROLOGY (2005)
Yeast model uncovers dual roles of mitochondria in the action of arternisinin
W Li et al.
PLOS GENETICS (2005)
Neurotoxicity due to antimalarial therapy associated with misdiagnosis of malaria
C Franco-Paredes et al.
CLINICAL INFECTIOUS DISEASES (2005)
Comment on: Audiometric changes associated with the treatment of uncomplicated falciparum malaria with co-artemether
H Reinhart et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2005)
In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem)
C Sisowath et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Mechanistic perspectives for 1,2,4-trioxanes in anti-cancer therapy
T Efferth
DRUG RESISTANCE UPDATES (2005)
Risk assessment and therapeutic indices of artesunate and artelinate in Plasmodium berghei - Infected and uninfected rats
LH Xie et al.
INTERNATIONAL JOURNAL OF TOXICOLOGY (2005)
Combination-treatment of glioblastoma multiforme cell lines with the anti-malarial artesunate and the epidermal growth factor receptor tyrosine kinase inhibitor OSI-774
T Efferth et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Artemisinin derivatives: toxic for laboratory animals, safe for humans?
T Gordi et al.
TOXICOLOGY LETTERS (2004)
Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron
T Efferth et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
Response to: artemisinin derivatives: toxic for laboratory animals, safe for humans?
S Toovey et al.
TOXICOLOGY LETTERS (2004)
Artemisinins: mechanisms of action and potential for resistance
S Krishna et al.
DRUG RESISTANCE UPDATES (2004)
Inhibition of angiogenesis in vivo and growth of Kaposi's sarcoma xenograft tumors by the anti-malarial artesunate
R Dell'Eva et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Antimalarial drug toxicity - A review
WRJ Taylor et al.
DRUG SAFETY (2004)
Developmental toxicity of artesunate and an artesunate combination in the rat and rabbit
RL Clark et al.
BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY (2004)
Oxidative stress response of tumor cells: microarray-based comparison between artemisinins and anthracyclines
T Efferth et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Audiometric changes associated with the treatment of uncomplicated falciparum malaria with co-artemether
S Toovey et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2004)
Artemisinins target the SERCA of Plasmodium falciparum
U Eckstein-Ludwig et al.
NATURE (2003)
Molecular modes of action of artesunate in tumor cell lines
T Efferth et al.
MOLECULAR PHARMACOLOGY (2003)
Antimalarial compounds: from bench to bedside
PL Olliaro et al.
JOURNAL OF EXPERIMENTAL BIOLOGY (2003)
The antimalaria agent artemisinin exerts antiangiogenic effects in mouse embryonic stem cell-derived embryoid bodies
M Wartenberg et al.
LABORATORY INVESTIGATION (2003)
Intramuscular bioavailability and clinical efficacy of artesunate in Gabonese children with severe malaria
C Nealon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
mRNA expression profiles for the response of human tumor cell lines to the antimalarial drugs artesunate, arteether, and artemether
T Efferth et al.
BIOCHEMICAL PHARMACOLOGY (2002)
The economic and social burden of malaria
J Sachs et al.
NATURE (2002)
Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells
T Efferth et al.
BLOOD CELLS MOLECULES AND DISEASES (2002)
Neurotoxic mode of action of artemisinin
G Schmuck et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
A meta-analysis using individual patient data of trials comparing artemether with quinine in the treatment of severe falciparum malaria
K Stepniewska et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2001)
Randomized comparison of quinine-clindamycin versus artesunate in the treatment of falciparum malaria in pregnancy
R McGready et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2001)
Effects of arteether on an auditory radial-arm maze task in rats
RF Genovese et al.
PHYSIOLOGY & BEHAVIOR (2001)
The role of glutathione in the neurotoxicity of artemisinin derivatives in vitro
SL Smith et al.
BIOCHEMICAL PHARMACOLOGY (2001)
Bioavailability and preliminary clinical efficacy of intrarectal artesunate in Ghanaian children with moderate malaria
S Krishna et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Pharmacokinetics of artemisinin-type compounds
V Navaratnam et al.
CLINICAL PHARMACOKINETICS (2000)
Behavioral and neural toxicity of the artemisinin antimalarial, arteether, but not artesunate and artelinate, in rats
RE Genovese et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2000)
The oral route for the administration of cytotoxic drugs: strategies to increase the efficiency and consistency of drug delivery
HA Bardelmeijer et al.
INVESTIGATIONAL NEW DRUGS (2000)
Neurological dysfunction following malaria: Disease- or drug-related?
NJ White
CLINICAL INFECTIOUS DISEASES (2000)
Arteether-induced brain injury in Macaca mulatta.: I.: The precerebellar nuclei:: the lateral reticular nuclei, paramedian reticular nuclei, and perihypoglossal nuclei
JM Petras et al.
ANATOMY AND EMBRYOLOGY (2000)
分享论文
